NICE 2001/027
Issued: 31 July 2001

Press release

The National Institute for Clinical Excellence today welcomed the announcement of additional topics for its forward work programme.

The Department of Health and the National Assembly for Wales have formally referred:

  • 14 technologies to the Institute for appraisal, which includes drugs to treat epilepsy and electroconvulsive therapy for patients with mental health problems
  • 10 clinical guidelines covering areas such as infertility services and Chronic Obstructive Pulmonary Disease (COPD)
  • 2 clinical audit topics on continence care for older people and parenteral nutrition in pre-term (premature) infants

Andrew Dillon, NICE Chief Executive said, "We have noted the referrals to the Institute of these technologies for appraisal and have today commenced work scheduling them into our ongoing work programmes. We have also begun negotiating with the Collaborating Centres who develop the clinical guidelines for the NHS to determine who will hold responsibility for each guideline. In line with our current practice I can confirm that we will publish details of the timetables for these topics on our web site before the end of August"

Ends

Notes for Editors

1. Web site address - www.nice.org.uk

2. The full list of topics is shown below:

Drugs and treatments:

  • New oral drugs for advanced breast and colorectal cancer (two separate appraisals)
  • New drugs for bipolar disorder (manic-depression)
  • Electroconvulsive therapy
  • Patient education models for diabetes
  • Insulin glargine and other long-acting insulin analogues
  • Insulin pump therapy for people with Type 1 diabetes
  • Immunosuppressive regimes for renal (kidney) transplantation
  • Home versus hospital dialysis
  • Raloxifene and other selective oestrogen receptor modulators (SERMs) for treatment of osteoporosis (subject to further consultation on the remit)
  • Tension-free vaginal tape for stress incontinence
  • Thermal endometrial ablation for heavy menstrual bleeding
  • New drugs for epilepsy
  • Anakinra for rheumatoid arthritis
  • Review of anti-viral drugs for prevention and treatment of influenza

Clinical Guideline and Clinical Audit topics:

  • Service guidance for cancers affecting children and adolescents.
  • Clinical guideline for the identification and management of genetic risk of familial breast cancer.
  • Clinical guideline on the diagnosis and treatment of lung cancer
  • Clinical guideline and audit tool for drug treatments and psychological therapies for anxiety and related common mental disorders
  • Clinical guideline on the short-term management of disturbed (violent) behaviour in inpatient psychiatric settings
  • Clinical guideline for the management of patients who intentionally harm themselves
  • Clinical guidelines and associated clinical audit systems on the assessment and prevention of falls in older people, including recurrent falls.
  • Clinical audit for continence
  • Clinical Guidelines for Infertility Services
  • Clinical guidelines for routine antenatal care
  • Prospective clinical audit of parenteral nutrition in pre-term infants
  • Clinical Guidelines for Epilepsy
  • Clinical Guideline for Chronic Obstructive Pulmonary Disease (COPD).

3. Full details are available in the Department of Health press release ref. 2001/0357 on the DoH website www.doh.gov.uk or from the press office on 020 7210 5649.